跳至主要内容
临床试验/EUCTR2020-001862-12-BE
EUCTR2020-001862-12-BE进行中(未招募)1 期

Early administration of Vitamin C in patients with sepsis or septic shock inemergency departments: a multicentre, double blinded, randomizedcontrolled trial: the C-EASIE trial. - The C-EASIE trial.

niversity Hospitals Leuven, Clinical Trial Centre0 个研究点目标入组 300 人开始时间: 2021年2月17日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Participants eligible for inclusion in this trial must meet all of the
  • following criteria:
  • 1. Patient is = 18 years old.
  • 2. Patient has a 'suspected infection': this requires the combination of AB administration and body fluid cultures within the first 6 hours after ED presentation.
  • 3. NEWS score = 5.
  • NEWS is based on a simple aggregate scoring system in which a score is allocated to physiological measurements, already recorded in routine practice, when patients present to the hospital. Six simple physiological parameters form the basis of the scoring system: respiration rate, oxygen saturation, systolic blood pressure, pulse rate, level of consciousness or new confusion and temperature.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 150
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 150

排除标准

  • Participants eligible for this trial must not meet any of the following criteria:
  • 1. Patient (=18 years old) or legally authorized representative (LAR) didn't provide informed consent. Delayed informed consent can be applied in cases where the patient is critically ill and no LAR is available
  • 2. AB administration as a single dose or as a prophylactic treatment.
  • 3. AB administered without an accompanying body fluid culture according to the timeframe (within 6 hours after ED presentation).
  • 4. 'Do no intubate' or 'comfort measures only' status.
  • 5. Failure to randomize within 6 hours.
  • 6. Weight < 45 kg.
  • 7. Pregnant or breastfeeding.
  • 8. Allergy for Vitamin C.
  • 9. Known history of oxalate nephropathy or hyperoxaluria.
  • 10. Known history of glucose-6-phosphate dehydrogenase deficiency.
  • 11. Known history of chronic iron overload due to iron storage and other diseases.
  • 12. The patient is already on IV steroids for a reason other than septic shock.
  • 13. Proven active COVID-19 infection (positive swab and/or CT scan positive for COVID).

研究者

发起方
niversity Hospitals Leuven, Clinical Trial Centre

相似试验

C-EASIE trial: Vitamin C - Early Administration in... | 临床试验